[AMRX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -18.75%
YoY- 505.10%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 701,780 659,191 616,981 620,040 599,046 557,540 609,759 9.83%
PBT 20,405 -75,522 -83,461 22,957 29,660 -9,426 -7,655 -
Tax 3,618 6,156 9,883 -2,076 -23 668 -1,797 -
NP 5,994 -91,643 -98,649 9,682 11,917 -10,094 -5,858 -
Tax Rate -17.73% - - 9.04% 0.08% - - -
Total Cost 695,786 750,834 715,630 610,358 587,129 567,634 615,617 8.51%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.85 -13.90 -15.99 1.56 1.99 -1.81 -0.96 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 0.02 -0.30 -0.40 0.06 0.08 -0.07 -0.04 -
EPS Diluted 0.02 -0.30 -0.40 0.06 0.08 -0.07 -0.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.